These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 24652107

  • 1. Effect of varenicline on aspects of inhibitory control in smokers.
    Austin AJ, Duka T, Rusted J, Jackson A.
    Psychopharmacology (Berl); 2014 Sep; 231(18):3771-85. PubMed ID: 24652107
    [Abstract] [Full Text] [Related]

  • 2. The effects of varenicline on attention and inhibitory control among treatment-seeking smokers.
    Rhodes JD, Hawk LW, Ashare RL, Schlienz NJ, Mahoney MC.
    Psychopharmacology (Berl); 2012 Sep; 223(2):131-8. PubMed ID: 22526531
    [Abstract] [Full Text] [Related]

  • 3. Effects of the alpha4beta2 partial agonist varenicline on brain activity and working memory in abstinent smokers.
    Loughead J, Ray R, Wileyto EP, Ruparel K, Sanborn P, Siegel S, Gur RC, Lerman C.
    Biol Psychiatry; 2010 Apr 15; 67(8):715-21. PubMed ID: 20207347
    [Abstract] [Full Text] [Related]

  • 4. Varenicline decreases alcohol consumption in heavy-drinking smokers.
    Mitchell JM, Teague CH, Kayser AS, Bartlett SE, Fields HL.
    Psychopharmacology (Berl); 2012 Oct 15; 223(3):299-306. PubMed ID: 22547331
    [Abstract] [Full Text] [Related]

  • 5. A double-blind randomized placebo-controlled pilot study of neuropsychiatric adverse events in abstinent smokers treated with varenicline or placebo.
    Garza D, Murphy M, Tseng LJ, Riordan HJ, Chatterjee A.
    Biol Psychiatry; 2011 Jun 01; 69(11):1075-82. PubMed ID: 21295286
    [Abstract] [Full Text] [Related]

  • 6. Effects of varenicline on smoking cue–triggered neural and craving responses.
    Franklin T, Wang Z, Suh JJ, Hazan R, Cruz J, Li Y, Goldman M, Detre JA, O'Brien CP, Childress AR.
    Arch Gen Psychiatry; 2011 May 01; 68(5):516-26. PubMed ID: 21199958
    [Abstract] [Full Text] [Related]

  • 7. Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up.
    Nides M, Oncken C, Gonzales D, Rennard S, Watsky EJ, Anziano R, Reeves KR.
    Arch Intern Med; 2011 May 01; 166(15):1561-8. PubMed ID: 16908788
    [Abstract] [Full Text] [Related]

  • 8. Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial.
    Gonzales D, Rennard SI, Nides M, Oncken C, Azoulay S, Billing CB, Watsky EJ, Gong J, Williams KE, Reeves KR, Varenicline Phase 3 Study Group.
    JAMA; 2006 Jul 05; 296(1):47-55. PubMed ID: 16820546
    [Abstract] [Full Text] [Related]

  • 9. Effect of varenicline and bupropion SR on craving, nicotine withdrawal symptoms, and rewarding effects of smoking during a quit attempt.
    West R, Baker CL, Cappelleri JC, Bushmakin AG.
    Psychopharmacology (Berl); 2008 Apr 05; 197(3):371-7. PubMed ID: 18084743
    [Abstract] [Full Text] [Related]

  • 10. The effects of varenicline on stress-induced and cue-induced craving for cigarettes.
    Ray LA, Lunny K, Bujarski S, Moallem N, Krull JL, Miotto K.
    Drug Alcohol Depend; 2013 Jul 01; 131(1-2):136-42. PubMed ID: 23298651
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial.
    Jorenby DE, Hays JT, Rigotti NA, Azoulay S, Watsky EJ, Williams KE, Billing CB, Gong J, Reeves KR, Varenicline Phase 3 Study Group.
    JAMA; 2006 Jul 05; 296(1):56-63. PubMed ID: 16820547
    [Abstract] [Full Text] [Related]

  • 12. Acute effects of mecamylamine and varenicline on cognitive performance in non-smokers with and without schizophrenia.
    Roh S, Hoeppner SS, Schoenfeld D, Fullerton CA, Stoeckel LE, Evins AE.
    Psychopharmacology (Berl); 2014 Feb 05; 231(4):765-75. PubMed ID: 24114425
    [Abstract] [Full Text] [Related]

  • 13. Varenicline attenuates some of the subjective and physiological effects of intravenous nicotine in humans.
    Sofuoglu M, Herman AI, Mooney M, Waters AJ.
    Psychopharmacology (Berl); 2009 Nov 05; 207(1):153-62. PubMed ID: 19693492
    [Abstract] [Full Text] [Related]

  • 14. Smoking cessation efficacy and safety of varenicline, an alpha4beta2 nicotinic receptor partial agonist.
    Tonstad S.
    J Cardiovasc Nurs; 2006 Nov 05; 21(6):433-6. PubMed ID: 17293731
    [Abstract] [Full Text] [Related]

  • 15. Varenicline: for smoking cessation.
    Rao J, Shankar PK.
    Kathmandu Univ Med J (KUMJ); 2009 Nov 05; 7(26):162-4. PubMed ID: 20071853
    [Abstract] [Full Text] [Related]

  • 16. Brain activity and emotional processing in smokers treated with varenicline.
    Loughead J, Ray R, Wileyto EP, Ruparel K, O'Donnell GP, Senecal N, Siegel S, Gur RC, Lerman C.
    Addict Biol; 2013 Jul 05; 18(4):732-8. PubMed ID: 21507156
    [Abstract] [Full Text] [Related]

  • 17. The impact of three weeks of pre-quit varenicline on reinforcing value and craving for cigarettes in a laboratory choice procedure.
    Lawson SC, Gass JC, Cooper RK, Tonkin SS, Colder CR, Mahoney MC, Tiffany ST, Hawk LW.
    Psychopharmacology (Berl); 2021 Feb 05; 238(2):599-609. PubMed ID: 33219852
    [Abstract] [Full Text] [Related]

  • 18. Varenicline for tobacco dependence.
    Hays JT, Ebbert JO.
    N Engl J Med; 2008 Nov 06; 359(19):2018-24. PubMed ID: 18987369
    [Abstract] [Full Text] [Related]

  • 19. [Varenicline - pharmacological therapy of tobacco dependence].
    Tschabitscher P, Homaier I, Lichtenschopf A, Groman E.
    Wien Med Wochenschr; 2009 Nov 06; 159(1-2):17-23. PubMed ID: 19225731
    [Abstract] [Full Text] [Related]

  • 20. Varenicline: a first-line treatment option for smoking cessation.
    Garrison GD, Dugan SE.
    Clin Ther; 2009 Mar 06; 31(3):463-91. PubMed ID: 19393839
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.